Associated Papers
MED12 exon 2 mutation is uncommon in intravenous leiomyomatosis: clinicopathologic features and molecular study.
Wang L et al.
Human Pathology, 2020
MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours.
Garcia-Dios DA et al.
British Journal of Cancer, 2018
Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.
Heinonen HR et al.
Scientific Reports, 2017
28432313 (PubMed )
Supplement: 41598_2017_1199_MOESM1_ESM.pdf
MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast.
Lien HC et al.
Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica, 2016
Frequent MED12 mutations in phyllodes tumours of the breast.
Yoshida M et al.
British Journal of Cancer, 2015
Select a paper to view details